Fungal Foot Infections Drug Development Pipeline Review, 2018

  • ID: 4496237
  • Report
  • 58 pages
  • GBI Research
1 of 5

FEATURED COMPANIES

  • Almirall SA
  • Biolab Farmaceutica Ltda
  • Dermala Inc
  • Helix BioMedix Inc
  • Meiji Seika Pharma Co Ltd
  • NAL Pharmaceuticals Ltd
  • MORE

Summary

Onychomycosis and athlete’s foot are nonlife-threatening fungal infections that most commonly affect the toenails and the feet respectively. Athlete’s foot affects 15% of the population globally, with males being more commonly affected than females. Onychomycosis affects roughly 10% of the global adult population.

There is considerable overlap in both the development of pipeline products and existing marketed products between the two indications, which reflects similarities in the underlying pathophysiology.

There are a total of 25 products in development across these indications, by 24 companies.

This report “Fungal Foot Infections Drug Development Pipeline Review, 2018” provides an overview of the onychomycosis (Tinea unguium) and athlete’s foot (Tinea pedis) pipeline landscapes. The report provides comprehensive information on the therapeutics under development and key players active in these two indications, and features dormant and discontinued projects.

Scope

  • Which companies are the most active within each pipeline?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

  • Understand the overall pipeline, with an at a glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an uptodate overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Almirall SA
  • Biolab Farmaceutica Ltda
  • Dermala Inc
  • Helix BioMedix Inc
  • Meiji Seika Pharma Co Ltd
  • NAL Pharmaceuticals Ltd
  • MORE

1 Introduction
1.1 Fungal Foot Infections Report Coverage
1.2 Onychomycosis (Tinea Unguium) - Overview
1.3 Tinea pedis (Athlete Foot) - Overview

2 Therapeutics Development
2.1 Onychomycosis (Tinea Unguium)
2.2 Tinea pedis (Athlete Foot)

3 Therapeutics Assessment
3.1 Onychomycosis (Tinea Unguium)
3.2 Tinea pedis (Athlete Foot)

4 Companies Involved in Therapeutics Development
4.1 Onychomycosis (Tinea Unguium)
4.2 Tinea pedis (Athlete Foot)

5 Dormant Projects
5.1 Onychomycosis (Tinea Unguium)
5.2 Tinea pedis (Athlete Foot)

6 Discontinued Products
6.1 Onychomycosis (Tinea Unguium)

7 Product Development Milestones
7.1 Onychomycosis (Tinea Unguium)
7.2 Tinea pedis (Athlete Foot)

8 Appendix
8.1 Methodology
8.2 Coverage
8.3 Secondary Research
8.4 Primary Research
8.5 Expert Panel Validation
8.6 Contact
8.7 Disclaimer

List of Tables
Table 1: Number of Products under Development for Onychomycosis (Tinea Unguium)
Table 2: Number of Products under Development by Companies, Onychomycosis (Tinea Unguium)
Table 3: Products under Development by Companies, Onychomycosis (Tinea Unguium)
Table 4: Number of Products under Development for Tinea pedis (Athlete Foot)
Table 5: Number of Products under Development by Companies, Tinea pedis (Athlete Foot)
Table 6: Products under Development by Companies, Tinea pedis (Athlete Foot)
Table 7: Number of Products by Stage and Target, Onychomycosis (Tinea Unguium)
Table 8: Number of Products by Stage and Mechanism of Action, Onychomycosis (Tinea Unguium)
Table 9: Number of Products by Stage and Route of Administration, Onychomycosis (Tinea Unguium)
Table 10: Number of Products by Stage and Molecule Type, Onychomycosis (Tinea Unguium)
Table 11: Number of Products by Stage and Target, Tinea pedis (Athlete Foot)
Table 12: Number of Products by Stage and Mechanism of Action, Tinea pedis (Athlete Foot)
Table 13: Number of Products by Stage and Route of Administration, Tinea pedis (Athlete Foot)
Table 14: Number of Products by Stage and Molecule Type, Tinea pedis (Athlete Foot)
Table 15: Onychomycosis (Tinea Unguium) - Pipeline by Almirall SA
Table 16: Onychomycosis (Tinea Unguium) - Pipeline by Blueberry Therapeutics Ltd
Table 17: Onychomycosis (Tinea Unguium) - Pipeline by Dermala Inc
Table 18: Onychomycosis (Tinea Unguium) - Pipeline by Eisai Co Ltd
Table 19: Onychomycosis (Tinea Unguium) - Pipeline by Helix BioMedix Inc
Table 20: Onychomycosis (Tinea Unguium) - Pipeline by Hexima Ltd
Table 21: Onychomycosis (Tinea Unguium) - Pipeline by Kaken Pharmaceutical Co Ltd
Table 22: Onychomycosis (Tinea Unguium) - Pipeline by Meiji Seika Pharma Co Ltd
Table 23: Onychomycosis (Tinea Unguium) - Pipeline by Moberg Pharma AB
Table 24: Onychomycosis (Tinea Unguium) - Pipeline by NAL Pharmaceuticals Ltd
Table 25: Onychomycosis (Tinea Unguium) - Pipeline by Novabiotics Ltd
Table 26: Onychomycosis (Tinea Unguium) - Pipeline by Novan Inc
Table 27: Onychomycosis (Tinea Unguium) - Pipeline by Viamet Pharmaceuticals Inc
Table 28: Tinea pedis (Athlete Foot) - Pipeline by Astellas Pharma Inc
Table 29: Tinea pedis (Athlete Foot) - Pipeline by Biolab Farmaceutica Ltda
Table 30: Tinea pedis (Athlete Foot) - Pipeline by Blueberry Therapeutics Ltd
Table 31: Tinea pedis (Athlete Foot) - Pipeline by Broda Tech LLC
Table 32: Tinea pedis (Athlete Foot) - Pipeline by Novan Inc
Table 33: Tinea pedis (Athlete Foot) - Pipeline by Novoteris LLC
Table 34: Tinea pedis (Athlete Foot) - Pipeline by Sanotize Research And Development Corp
Table 35: Tinea pedis (Athlete Foot) - Pipeline by Viamet Pharmaceuticals Inc
Table 36: Onychomycosis (Tinea Unguium) - Dormant Projects
Table 37: Tinea pedis (Athlete Foot) - Dormant Projects
Table 38: Onychomycosis (Tinea Unguium) - Discontinued Products

List of Figures
Figure 1: Number of Products under Development for Onychomycosis (Tinea Unguium)
Figure 2: Number of Products under Development by Companies, Onychomycosis (Tinea Unguium)
Figure 3: Number of Products under Development for Tinea pedis (Athlete Foot)
Figure 4: Number of Products under Development by Companies, Tinea pedis (Athlete Foot)
Figure 5: Number of Products by Targets, Onychomycosis (Tinea Unguium)
Figure 6: Number of Products by Stage and Targets, Onychomycosis (Tinea Unguium)
Figure 7: Number of Products by Mechanism of Actions, Onychomycosis (Tinea Unguium)
Figure 8: Number of Products by Stage and Mechanism of Actions, Onychomycosis (Tinea Unguium)
Figure 9: Number of Products by Routes of Administration, Onychomycosis (Tinea Unguium)
Figure 10: Number of Products by Stage and Routes of Administration, Onychomycosis (Tinea Unguium)
Figure 11: Number of Products by Molecule Types, Onychomycosis (Tinea Unguium)
Figure 12: Number of Products by Stage and Molecule Types, Onychomycosis (Tinea Unguium)
Figure 13: Number of Products by Targets, Tinea pedis (Athlete Foot)
Figure 14: Number of Products by Stage and Targets, Tinea pedis (Athlete Foot)
Figure 15: Number of Products by Mechanism of Actions, Tinea pedis (Athlete Foot)
Figure 16: Number of Products by Stage and Mechanism of Actions, Tinea pedis (Athlete Foot)
Figure 17: Number of Products by Routes of Administration, Tinea pedis (Athlete Foot)
Figure 18: Number of Products by Stage and Routes of Administration, Tinea pedis (Athlete Foot)
Figure 19: Number of Products by Stage and Molecule Types, Tinea pedis (Athlete Foot)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Almirall SA
  • Astellas Pharma Inc
  • Biolab Farmaceutica Ltda
  • Blueberry Therapeutics Ltd
  • Broda Tech LLC
  • Dermala Inc
  • Eisai Co Ltd
  • Helix BioMedix Inc
  • Hexima Ltd
  • Kaken Pharmaceutical Co Ltd
  • Meiji Seika Pharma Co Ltd
  • Moberg Pharma AB
  • NAL Pharmaceuticals Ltd
  • Novabiotics Ltd
  • Novan Inc
  • Novoteris LLC
  • Onychomycosis (Tinea Unguium)
  • Sanotize Research And Development Corp
  • Tinea pedis (Athlete Foot)
  • Viamet Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll